TRADE POLICY | 2026-04-20

Section 232 Pharmaceutical Tariffs 2026 | Trade Attorney CA

Trump's April 2026 Section 232 Executive Order Imposes 100% Tariff on Patented Pharmaceutical Imports — What California Life Science, Biotech, and Pharmaceutical Importers Must Know Before July 31, 2026

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

Section 232 pharmaceutical tariffs became reality on April 2, 2026, when President Trump signed an Executive Order invoking Section 232 of the Trade Expansion Act of 1962 to impose a 100% tariff on patented pharmaceutical products and pharmaceutical ingredients imported into the United States. The order targets more than 130 specified HTSUS subheadings. For 17 named major drug companies, these tariffs take effect July 31, 2026.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301